1
Diabetes melitus. Curcumina diminui resistência periférica à insulina no tecido muscular 25/08/10 A curcumina diminui a glicemia, o colesterol e os triglicérides e facilita o emagrecimento de diabéticos. Agora foi provado que ela aumenta a sensibilidade periférica à insulina, o que facilita a entrada de glicose nas células. Curcumin improves insulin resistance in skeletal muscle of rats. Na LX, Zhang YL, Li Y, Liu LY, Li R, Kong T, Sun CH. Nutr Metab Cardiovasc Dis. 2010 Mar 12. Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, Harbin 150086, PR China. Abstract BACKGROUND AND AIMS: Curcumin has been reported to lower plasma lipids and glucose in diabetic rats, and to decrease body weight in obese rats, which may partly be due to increased fatty acid oxidation and utilization in skeletal muscle. METHODS AND RESULTS: Diabetic rats induced by high-fat diet plus streptozotocin (STZ, 30mg/kg BW) were fed a diet containing 50, 150, or 250mg/kg BW curcumin for 7 wk. Curcumin dose-dependently decreased plasma lipids and glucose and the dose 150mg/kg BW appeared to be adequate to produce a significant effect. Curcumin supplementation reduced glucose and insulin tolerance measured as areas under the curve. L6 myotubes were treated with palmitate (0.25mmol/L) in the presence of different levels of curcumin for 24 h in our in vitro experiment. Curcumin at 10mumol/L was adequate to cause a significant increase in 2-deoxy-[(3)H]d-glucose uptake by L6 myotubes. Curcumin up-regulated expression of phosphorylated AMP-activated protein kinase (AMPK), CD36, and carnitine palmitoyl transferase 1, but down-regulated expression of pyruvate dehydrogenase 4 and phosphorylated glycogen synthase (GS) in both in vivo and in vitro studies. Moreover, curcumin increased phosphorylated acetyl COA carboxylase in L6 myotubes. The effects of curcumin on these enzymes except for GS were suppressed by AMPK inhibitor, Compound C. LKB1, an upstream kinase of AMPK, was activated by curcumin and inhibited by radicicol, an LKB1 destabilizer. CONCLUSION: Curcumin improves muscular insulin resistance by increasing oxidation of fatty acid and glucose, which is, at least in part, mediated through LKB1-AMPK pathway. PMID: 20227862 do-0222.pdf http://www.medicinacomplementar.com.br/convertido/do-0222.htm 1 de 1 30/9/2011 11:15

Diabetes melitus. Curcumina diminui resistência periférica ... · Diabetes melitus. Curcumina diminui resistência periférica à insulina no tecido muscular 25/08/10 A curcumina

  • Upload
    vuhuong

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Diabetes melitus. Curcumina diminui resistência periférica ... · Diabetes melitus. Curcumina diminui resistência periférica à insulina no tecido muscular 25/08/10 A curcumina

Diabetes melitus. Curcumina diminui resistência periférica à insulina no

tecido muscular

25/08/10

A curcumina diminui a glicemia, o colesterol e os triglicérides e facilita o emagrecimento de diabéticos. Agora foi provado que elaaumenta a sensibilidade periférica à insulina, o que facilita a entrada de glicose nas células.

Curcumin improves insulin resistance in skeletal muscle of rats.

Na LX, Zhang YL, Li Y, Liu LY, Li R, Kong T, Sun CH. Nutr Metab Cardiovasc Dis. 2010 Mar 12.Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, Harbin 150086, PR China.

Abstract

BACKGROUND AND AIMS: Curcumin has been reported to lower plasma lipids and glucose in diabetic rats, and to decrease body weightin obese rats, which may partly be due to increased fatty acid oxidation and utilization in skeletal muscle. METHODS AND RESULTS:Diabetic rats induced by high-fat diet plus streptozotocin (STZ, 30mg/kg BW) were fed a diet containing 50, 150, or 250mg/kg BWcurcumin for 7 wk. Curcumin dose-dependently decreased plasma lipids and glucose and the dose 150mg/kg BW appeared to beadequate to produce a significant effect. Curcumin supplementation reduced glucose and insulin tolerance measured as areas under thecurve. L6 myotubes were treated with palmitate (0.25mmol/L) in the presence of different levels of curcumin for 24 h in our in vitroexperiment. Curcumin at 10mumol/L was adequate to cause a significant increase in 2-deoxy-[(3)H]d-glucose uptake by L6 myotubes.Curcumin up-regulated expression of phosphorylated AMP-activated protein kinase (AMPK), CD36, and carnitine palmitoyltransferase 1, but down-regulated expression of pyruvate dehydrogenase 4 and phosphorylated glycogen synthase (GS) inboth in vivo and in vitro studies. Moreover, curcumin increased phosphorylated acetyl COA carboxylase in L6 myotubes. The effectsof curcumin on these enzymes except for GS were suppressed by AMPK inhibitor, Compound C. LKB1, an upstream kinase of AMPK,was activated by curcumin and inhibited by radicicol, an LKB1 destabilizer. CONCLUSION: Curcumin improves muscular insulinresistance by increasing oxidation of fatty acid and glucose, which is, at least in part, mediated through LKB1-AMPK pathway.PMID: 20227862

do-0222.pdf http://www.medicinacomplementar.com.br/convertido/do-0222.htm

1 de 1 30/9/2011 11:15